Axsome Therapeutics
AXSM
AXSM
244 hedge funds and large institutions have $3.12B invested in Axsome Therapeutics in 2023 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 70 increasing their positions, 88 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 226 → 244 (+18)
2.6% more ownership
Funds ownership: 80.28% → 82.88% (+2.6%)
20% less repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 88
Holders
244
Holding in Top 10
13
Calls
$79.2M
Puts
$41.4M
Top Buyers
| 1 | +$62.9M | |
| 2 | +$37.2M | |
| 3 | +$27.2M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$20.4M |
| 5 |
BlackRock
New York
|
+$20.4M |
Top Sellers
| 1 | -$65.3M | |
| 2 | -$20.9M | |
| 3 | -$16.6M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$13.8M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$10M |